Organization typesPublic Company

Products 61 to 70 of 122

PCR-produced linear DNA by Applied DNA Sciences + LineaRx
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/01/30 11:54 (3 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Platform
Biotech components: Enzyme
Business models: B2B
Country of production: Denmark
Country of distribution: Denmark + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/08 14:50 (3 years ago)
Known funding amount: 12,880,000 DKK
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: NZYM-B (CPH)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/09/28 15:00 (3 years ago)
Known funding amount: 608,825,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: CLXT (NASDAQ)
Value chain stage: Finished Product
Lux Algal Oil Soap by Lux (Unilever)
Biotech components: Plant
Business models: B2C
Country of production: UK
Country of distribution: Brazil + UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: ULVR (LSE)
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical + Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/16 16:29 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input